X0306 4 2021-07-15 0000748592 Brooklyn ImmunoTherapeutics, Inc. BTX 0001873057 Sial Jay C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220 true See Remarks Stock Option 10.31 2021-07-15 4 A 0 71000 0 A 2031-07-15 Common Stock 71000 71000 D Restricted Stock Unit 2021-07-15 4 A 0 35700 0 A 2031-07-15 Common Stock 35700 35700 D The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on July 15, 2022, and 1/36 of the remaining shares covered thereby vesting on the 15th day of each calendar month from August 2022 through July 15, 2025, subject to continued service through each vesting date. Each restricted stock unit represents a contingent right to receive one share of common stock. The RSU Grant vests and becomes exercisable in four equal installments on July 15 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Mr. Sial's Executive Employment Agreement, dated as of July 6, 2021 and effective July 15, 2021), subject to continued service through each vesting date. Chief Administrative Officer /s/Mark L. Johnson, Attorney-in-Fact for Jay Sial 2021-07-19